Rezultati pretraživanja
  1. buyers finding it hard to find volume. May have to push it to find sellers. Stayed tuned.

  2. breaks above 50 day. Moving back to highs.

  3. Major changes in stock price 4.18 % change recently

  4. prije 14 sati
    Odgovor korisnicima

    For does anyone know the exact time when the 1st interm occurred (25% of events) and 2nc interm occurred (75% of events)?

  5. 4. velj
  6. 4. velj
  7. 4. velj

    Mon (2/3/20) weakest final 30-min close (Min $5 & Vol 750K, Opt Min Vol 500 in any strike):

  8. 3. velj

    Sold (-9.2%), (-14.3%). 125% long by 28% short. 33% long Technology, 29% long Health Care, 13% long Finance, 7% long Consumer Services.

  9. 1. velj

    Does company know 1) how many Pd events have occurred on a weekly basis and 2) what the actual target number of Pd events is in order to trigger the TL data analysis and readout, and 3) How long from that Pd data trigger event through analysis to issue TL data PR?

  10. 31. sij

    taking advantage current weakness to add to my core position currently at 80%. Many (including me) expected Boston data early to mid January. Company says Jan to April. Market and weakness giving me an opportunity to add at a discount. MMA Boston and earnings on deck

  11. 31. sij

    shakes out non-believers before data release, similar to did in Q4 19

  12. 31. sij

    Boston study results in Q1? timing is event driven

  13. 31. sij

    we’ll I got my add at $15.85

  14. 30. sij
  15. 29. sij
    Odgovor korisniku/ci

    FDA ODAC briefing document for Selinexor confirms that was aiming for patients with at least three prior lines therapy, triple refractory, triple-class refractory. So pentarefractory was not their aim.

  16. 29. sij

    Tues (1/28/20) highest trading range compared to open > 80% (Min $5 & Vol 750K, Opt Min Vol 250 in any strike):

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.